2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 230.397 | 230.568 | 215.978 | 264.964 | 231.085 | 219.297 | 261.307 | 255.267 | 272.171 | 309.722 |
Total Income - EUR | 290.642 | 257.233 | 220.570 | 266.597 | 232.837 | 221.015 | 261.884 | 255.550 | 278.276 | 317.453 |
Total Expenses - EUR | 239.567 | 222.587 | 210.320 | 255.165 | 209.747 | 192.514 | 232.249 | 242.197 | 246.084 | 296.450 |
Gross Profit/Loss - EUR | 51.075 | 34.647 | 10.251 | 11.433 | 23.090 | 28.500 | 29.635 | 13.353 | 32.192 | 21.004 |
Net Profit/Loss - EUR | 43.105 | 29.427 | 8.262 | 8.779 | 20.826 | 26.397 | 27.223 | 11.028 | 29.919 | 18.293 |
Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Farmacia Pro Sana S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 105.527 | 97.438 | 89.775 | 77.894 | 68.020 | 63.558 | 59.867 | 54.933 | 50.627 | 46.823 |
Current Assets | 210.515 | 240.658 | 207.101 | 129.562 | 122.725 | 114.534 | 127.508 | 129.330 | 141.419 | 162.178 |
Inventories | 147.592 | 159.667 | 162.036 | 87.159 | 68.024 | 70.883 | 73.396 | 80.830 | 90.802 | 104.025 |
Receivables | 46.001 | 33.193 | 14.617 | 37.446 | 51.646 | 37.850 | 46.582 | 46.553 | 48.883 | 51.760 |
Cash | 16.922 | 47.797 | 30.448 | 4.958 | 3.055 | 5.801 | 7.530 | 1.947 | 1.734 | 6.393 |
Shareholders Funds | 149.958 | 180.636 | 9.324 | 17.946 | 38.442 | 64.094 | 62.682 | 58.170 | 60.489 | 78.598 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 166.288 | 157.461 | 287.551 | 189.511 | 152.303 | 113.999 | 124.692 | 126.093 | 131.557 | 130.402 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacia Pro Sana S.r.l.